Usability evaluation with mental health professionals and young people to develop an Internet-based cognitive-behaviour therapy program for adolescents with anxiety disorders

Meta-analysis: The Effectiveness of Youth Psychotherapy Interventions in Low- and Middle-Income Countries

Treatment of child anxiety disorders via guided parent-delivered cognitive–behavioural therapy: Randomised controlled trial

Digital mental health: small steps for big gains

CCBY Open access Research Methods & Reporting A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance

Parent-Led Cbt Delivered Via Online and Telephone Support

Development of a brief assessment tool to identify children with probable anxiety disorders

Identifying Child Anxiety Through Schools-identification to intervention (iCATS-i2i)

Seeking and accessing professional support for child anxiety in a community sample

What do parents perceive are the barriers and facilitators to accessing psychological treatment for mental health problems in children and adolescents?

Guided parent-delivered cognitive behavioural therapy for Japanese children and parents: a single-arm uncontrolled study

Adapting interventions to new contexts—the ADAPT guidance

Mental health care in Pakistan boosted by the highest office

Towards a comprehensive model for understanding adaptations' impact: the model for adaptation design and impact (MADI)

Cognitive behavioural therapy for anxiety disorders in children and adolescents

A randomized controlled trial of a bidirectional cultural adaptation of cognitive behavior therapy for children and adolescents with anxiety disorders

Online Support and Intervention (OSI) for child anxiety: a case series within routine clinical practice

Formal Implementation of Cost-Effectiveness Evaluations in Japan: A Unique Health Technology Assessment System

Beyond Adoption: A New Framework for Theorizing and Evaluating Nonadoption, Abandonment, and Challenges to the Scale-Up, Spread, and Sustainability of Health and Care Technologies

Increasing access to evidence-based treatment for child anxiety problems: online parent-led CBT for children identified via schools

Cost-effectiveness of implementing a digital psychosocial intervention for patients with psychotic spectrum disorders in low- and middle-income countries in Southeast Europe

Evolving child and adolescent mental health and development programs in Chile

Digitally augmented, parent-led CBT versus treatment as usual for child anxiety problems in child mental health services in England and Northern Ireland

Parent-led cognitive behaviour therapy for child anxiety problems: overcoming challenges to increase access to effective treatment

Neurodevelopmental Outcomes After Late Preterm Antenatal Corticosteroids: The ALPS Follow-Up Study

The Antenatal Late Preterm Steroids (ALPS) trial changed clinical practice in the United States by finding that antenatal betamethasone at 34 to 36 weeks decreased short-term neonatal respiratory morbidity. However, the trial also found increased risk of neonatal hypoglycemia after betamethasone. This follow-up study focused on long-term neurodevelopmental outcomes after late preterm steroids. In this follow-up study of a randomized clinical trial, administration of antenatal corticosteroids to persons at risk of late preterm delivery, originally shown to improve short-term neonatal respiratory outcomes but with an increased rate of hypoglycemia, was not associated with adverse childhood neurodevelopmental outcomes at age 6 years or older.

Association of Birth During the COVID-19 Pandemic With Neurodevelopmental Status at 6 Months in Infants With and Without In Utero Exposure to Maternal SARS-CoV-2 Infection

The objective of this study was to examine the associations between maternal SARS-CoV-2 infection during pregnancy, being born during the COVID-19 pandemic regardless of maternal SARS-CoV-2 status, and neurodevelopment at age 6 months. In this study, birth during the pandemic, but not in utero exposure to maternal SARS-CoV-2 infection, was associated with differences in neurodevelopment at age 6 months. These early findings support the need for long-term monitoring of children born during the COVID-19 pandemic.